A randomized controlled efficacy trial of mindfulness-based stress reduction compared with an active control group and usual care for fibromyalgia: The EUDAIMON study
Pain Nov 07, 2019
Pérez-Aranda A, Feliu-Soler A, Montero-Marín J, et al. - Researchers investigated whether mindfulness-based stress reduction (MBSR) is effective in reducing functional impairment in people with fibromyalgia (FM). Further, they appraised the role of mindfulness-related constructs as mediators of treatment outcomes in these people. Randomization of 225 participants with FM into 3 study arms was done: MBSR plus treatment-as-usual (TAU), FibroQoL (multicomponent intervention for FM) plus TAU, and TAU alone. Findings suggest the superiority of MBSR to TAU both at posttreatment (large effect sizes) and at follow-up (medium to large effect sizes), and indicate its superiority to FibroQoL posttreatment (medium to large effect sizes), but in the long term, it was only modestly better (significant differences only in pain catastrophizing and fibromyalginess). Immediately posttreatment, the number required to treat for 20% improvement in MBSR vs TAU and FibroQoL was 4.0 (95% confidence interval [CI] = 2.1-6.5) and 5.0 (95% CI = 2.7-37.3). For FibroQoL vs TAU, they identified an unreliable number needed to treat value of 9 (not computable 95% CI). Psychological inflexibility and the mindfulness facet acting with awareness mediated the changes produced by MBSR in functional impact.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries